(RR/SS)-trans-1,2-Diaminocyclohexane[2-(4-{10,15,20-tris[4-(poly(ethylene glycol)-750-monomethyl ether-1-yl)phenyl] porphyrin-5-yl}phenoxy)malonato]platinum (II)

ID: ALA2068525

Max Phase: Preclinical

Molecular Formula: C158H252N6O59Pt

Molecular Weight: 3374.82

Molecule Type: Unknown

Alternative Forms

1. Parent:

   

   ALA2068525

   Platinum complex

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 3374.82

Molecular Weight (Monoisotopic): 3372.6551

AlogP: ┄

#Rotatable Bonds: ┄

Polar Surface Area: ┄

Molecular Species: ┄

HBA: ┄

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): ┄

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: ┄

CX LogD: ┄

Aromatic Rings: ┄

Heavy Atoms: ┄

QED Weighted: ┄

Np Likeness Score: ┄

References

1. Lottner C, Bart KC, Bernhardt G, Brunner H..  (2002)  Soluble tetraarylporphyrin-platinum conjugates as cytotoxic and phototoxic antitumor agents.,  45  (10): [PMID:11985475] [10.1021/jm0110690]

Source

Source(1):

• Scientific Literature